Stockholm-based Contract development and manufacturing organization (CDMO) Recipharm has received European Medicines Verification Organisation (EMVO) approval to submit serialization data to the European Hub.
The connection, facilitated by the company’ strategic partner TraceLink, represents a key milestone in Recipharm’s preparations for the Falsified Medicines Directive (FMD).


















